Bo Shen

Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials

D. Schrump, R. Fietkau, Jian-Guo Zhou, 2021, Frontiers in Immunology.

Topological Abnormalities of Pallido-Thalamo-Cortical Circuit in Functional Brain Network of Patients With Nonchemotherapy With Non-small Cell Lung Cancer

Jian-zhong Wu, Jifeng Feng, Chenchen Li, 2022, Frontiers in Neurology.

Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC

Qin Pan, Jinjun Ye, Zhi Zhang, 2023, Frontiers in Oncology.

Identification of differentially expressed genes between the colon and ileum of patients with inflammatory bowel disease by gene co-expression analysis

Yuting Zhang, Yong Xie, Liya Zhuge, 2019, The Journal of international medical research.

Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO

S. Wen, Guoren Zhou, Weiwei Peng, 2022, BMC cancer.

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

Luqing Zhao, Jifeng Feng, Shao-rong Yu, 2023, Frontiers in Oncology.

Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.

Juping Du, Shuaishuai Chen, Jun Li, 2018, Clinica chimica acta; international journal of clinical chemistry.

Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis

Yuting Zhang, Kun Li, Bo Shen, 2020, FEBS open bio.

Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial

Ban-zhou Pan, Zhengxiang Han, Yuan Wu, 2023, Investigational New Drugs.